Over the past three years, The Tisch Cancer Institute (TCI) has allocated funds for the development of both a Human Immune Monitoring Center and a Hematological Malignancies Tissue Bank
The Human Immune Monitoring Center was identified as a critical service for enhancing research in cancer immunotherapies, a major focus of the Cancer Immunology program.
A Hematological Malignancies Tissue Bank was identified as crucial for advancing work focused on malignant hematology in both our Cancer Mechanisms and Cancer Immunology programs.
Most recently, TCI has initiated the development of a Vaccine and Cell Therapy Facility. This new facility represents another critical service for research in cancer immunotherapies and functions synergistically with the Human Immune Monitoring Center.
